PGE have completed the first phase of seabed preparation for the Baltica 2 offshore wind farm in the Baltic Sea, marking a key step ahead of cable installation.

You may have missed it due to the firehose of international news over the last week. But in between the CIA director traveling to Venezuela to meet deposed dictator Nicolás Maduro’s replacement and ...

A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...

President Donald Trump’s administration formally launched the second phase of its plan to end the war between Israel and Hamas this week, shifting from a ceasefire framework toward a post-ceasefire ...

WASHINGTON — The White House announced the start of “Phase Two” of President Trump’s Gaza peace process Wednesday — despite Hamas refusing to disarm. The administration entered the new phase ...

The Trump administration on Wednesday announced the launch of the second phase of President Donald Trump’s 20-point peace plan for Gaza, seeking to shore up the fragile ceasefire between Hamas and ...

White House Middle East envoy Steve Witkoff on Wednesday announced the long-delayed launch of Phase 2 of President Donald Trump’s 20-point peace plan for Gaza, establishing a committee of Palestinian ...

The current era of Stranger Things is officially over, bookended by a new documentary that aired yesterday on Netflix and was picked apart by jilted fans, but was, in reality, pretty standard ...

Welcome to the Daily News Brief, CFR’s flagship morning newsletter summarizing the top global news and analysis of the day. What Hamas is saying. Naim, who is based in Qatar, said Hamas is open to ...

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) released topline data on Wednesday from its Phase 2 trial of silevertinib in frontline (1L) non-small cell lung cancer (NSCLC) patients with ...

Company remains on track to report interim results from approximately 25 six-month evaluable BCG-Unresponsive patients in the registrational cohort of the ADVANCED-2 trial in Q1 2026 Company expects ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that the first participant has been enrolled in the BLOOM Phase 2 ...